Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

Market Cap	1.22B
Revenue (ttm)	1.02B
Net Income (ttm)	45.75M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	26.57
Forward PE	17.58
Dividend	0.03 (3.91%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	18
Open	0.7600
Previous Close	0.7600
Day's Range	0.7600 - 0.7600
52-Week Range	0.5650 - 0.9700
Beta	n/a
RSI	49.19
Earnings Date	Mar 26, 2026

About FRA:XIN

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 7,296
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XIN

Financial Performance

In 2024, FRA:XIN's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY